{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:52:39Z","timestamp":1786719159385,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijem.ijem_525_18","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T03:49:08Z","timestamp":1552880948000},"page":"122","source":"Crossref","is-referenced-by-count":6,"title":["Role of procalcitonin as a predictor of clinical outcome in acute diabetic foot infections: A prospective study"],"prefix":"10.4103","volume":"23","author":[{"given":"AdlyneR","family":"Asirvatham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PraveenV","family":"Pavithran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JayakumarR","family":"Vasukutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bhavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AjitK","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MangalanandanT","family":"Sukumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.254453-1","first-page":"1414","volume-title":"Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-8210.254453-2","first-page":"438","volume-title":"The epidemiology of foot lesions in diabetic patients aged 15-50 years","author":"Borssen","year":"1990","journal-title":"Diabet Med"},{"key":"key-10.4103\/2230-8210.254453-3","first-page":"S83","volume-title":"Diagnosing foot infection in diabetes","author":"Williams","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2230-8210.254453-4","first-page":"305","volume-title":"Procalcitonin as a diagnostic aid in diabetic foot infections","author":"Uzun","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"key-10.4103\/2230-8210.254453-5","first-page":"382","volume-title":"Incidence, outcomes, and cost of foot ulcers in patients with diabetes","author":"Ramsey","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-8210.254453-6","first-page":"224","volume-title":"Value of white blood cell count with differential in acute diabetic foot infection","author":"Armstrong","year":"1996","journal-title":"J Am Podiatr Med Assoc"},{"key":"key-10.4103\/2230-8210.254453-7","first-page":"40","volume-title":"The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis","author":"Van","year":"2015","journal-title":"Int Wound J"},{"key":"key-10.4103\/2230-8210.254453-8","first-page":"286","volume-title":"Predictors of amputation in diabetics with foot ulcer: Single center experience in a large Turkish cohort","author":"Yesil","year":"2009","journal-title":"Hormones"},{"key":"key-10.4103\/2230-8210.254453-9","first-page":"e13376","volume-title":"Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?","author":"Jafari","year":"2014","journal-title":"Int J Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.254453-10","first-page":"31","volume-title":"The role of procalcitonin as a marker of diabetic foot ulcer infection","author":"Massara","year":"2017","journal-title":"Int Wound J"},{"key":"key-10.4103\/2230-8210.254453-11","first-page":"e132","volume-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","author":"Lipsky","year":"2012","journal-title":"Clin Infec Dis"},{"key":"key-10.4103\/2230-8210.254453-12","first-page":"S90","volume-title":"Diabetic foot ulcer classification system for research purposes: A progress report on criteria for including patients in research studies","author":"Schaper","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"key-10.4103\/2230-8210.254453-13","first-page":"214","volume-title":"Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection.A pilot study?","author":"Altay","year":"2012","journal-title":"J Diabetes Complications"},{"key":"key-10.4103\/2230-8210.254453-14","first-page":"51","volume-title":"Role of procalcitonin in infected diabetic foot ulcer","author":"Park","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"key-10.4103\/2230-8210.254453-15","first-page":"1306","volume-title":"Ulcer-free survival following management of foot ulcers in diabetes","author":"Pound","year":"2005","journal-title":"Diabet Med"},{"key":"key-10.4103\/2230-8210.254453-16","first-page":"32","volume-title":"Independent risk factors for amputation in diabetic foot","author":"Shojaiefard","year":"2008","journal-title":"Int J Diabetes Dev Ctries"},{"key":"key-10.4103\/2230-8210.254453-17","first-page":"951","volume-title":"The 14-year incidence of lower extremity amputations in a diabetic population.The Wisconsin epidemiologic study of diabetic retinopathy","author":"Moss","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-8210.254453-18","first-page":"1036","volume-title":"A prospective study of risk factors for diabetic foot ulcer.The Seattle diabetic foot study","author":"Boyko","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2230-8210.254453-19","first-page":"43","volume-title":"The association between clinical risk factors and outcome of diabetic foot ulcer","author":"Apalqvist","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"key-10.4103\/2230-8210.254453-20","first-page":"265","volume-title":"Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?","author":"Harrison","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.4103\/2230-8210.254453-21","first-page":"266","volume-title":"Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting","author":"Deliberato","year":"2013","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:44:36Z","timestamp":1786715076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.IJEM_525_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["254453"],"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_525_18","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}